
Esobia IV 40mg Injection
Marketer
Albia Biocare
Salt Composition
Esomeprazole (40mg)
Overview Esobia IV 40mg Injection
Intravenous Esobia (40mg) is a medication that suppresses gastric acid secretion. It's indicated for acid-related gastrointestinal disorders, including reflux and other conditions stemming from hyperacidity. This injection also prevents stress ulcers in critically ill patients and is prophylactically administered pre-anesthesia to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), it's administered intravenously by a healthcare provider only when deemed clinically superior to oral formulations. Dosage and treatment length are determined by individual needs and response. Optimizing treatment involves consuming smaller, more frequent meals and avoiding caffeine, spicy foods, and high-fat items. Common, generally mild, adverse effects encompass injection site reactions, nausea, headache, vertigo, flatulence, diarrhea, abdominal pain, and fundic gland polyps. Persistent or bothersome symptoms necessitate medical consultation. Discuss bone density preservation strategies, such as calcium and vitamin D supplementation, with your physician. Esobia IV 40mg is contraindicated in certain individuals. Inform your doctor of severe hepatic impairment, concomitant HIV medication use, prior PPI allergy, or pre-existing osteoporosis before receiving this injection. Pregnant or lactating individuals should seek medical advice. Alcohol consumption should be avoided due to its potential for increased gastric acid production and symptom exacerbation.
Uses of Esobia IV 40mg Injection
Managing gastroesophageal reflux disease (GERD)
Major Benefits of Esobia IV 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Esobia IV 40mg Injection:
- Injection site reaction
- Headache
- Dizziness
- Dryness in mouth
- Nausea
- Abdominal pain
- Constipation
- Flatulence
- Diarrhea
- Fundic gland polyps
How to use Esobia IV 40mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Esobia IV 40mg Injection works:
Intravenous Esobia, a 40mg proton pump inhibitor, diminishes gastric acid production, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Esobia IV 40mg Injection concurrently with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Administering Esobia IV 40mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Administering Esobia IV 40mg Injection while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Esobia IV 40mg Injection on driving ability is undetermined. Refrain from operating a vehicle should you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Administering Esobia IV 40mg Injection requires caution in patients exhibiting severe renal impairment; dosage modification may be necessary. Seek medical advice. Dosage alteration is unnecessary for individuals with mild or moderate kidney dysfunction.
LiverCAUTION
The administration of Esobia IV 40mg Injection requires careful consideration in individuals exhibiting severe hepatic impairment, potentially necessitating dosage modification. Consult your physician for guidance. Dosage alteration is unnecessary for patients with mild or moderate liver dysfunction.
What if you forget to take Esobia IV 40mg Injection :
Omitting a scheduled dose of Esobia IV 40mg Injection necessitates contacting your physician.
Facts to Know About Esobia IV 40mg Injection
| Label | Value |
|---|---|
| Type of Compound | Benzimidazole sulfone |
| Addictive | None. |
| Treatment Category | Digestive system |
| Mechanism of Action | Gastric acid secretion suppressants |
